Genmab A/S (OTCMKTS:GNMSF - Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $195.82 and traded as high as $209.75. Genmab A/S shares last traded at $209.75, with a volume of 61 shares.
Genmab A/S Stock Down 1.0%
The firm has a 50 day moving average of $196.46 and a 200 day moving average of $205.49. The firm has a market cap of $13.73 billion, a price-to-earnings ratio of 11.86 and a beta of 1.02.
Genmab A/S (OTCMKTS:GNMSF - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $3.05 EPS for the quarter, beating analysts' consensus estimates of $1.88 by $1.17. Genmab A/S had a return on equity of 19.75% and a net margin of 36.30%. The firm had revenue of $765.14 million during the quarter, compared to analysts' expectations of $761.09 million.
About Genmab A/S
(
Get Free Report)
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.
See Also
Before you consider Genmab A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genmab A/S wasn't on the list.
While Genmab A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
